Tyson Foods, Inc.
51.74USD
-0.5400 (-1.03%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.12▼ | $1.23 | 1 | 7 |
| Next quarter | $1.11▼ | $1.12 | 2 | 5 |
| Current year | $3.95▼ | $4.08 | 3 | 7 |
| Next year | $4.48▼ | $4.56 | 3 | 5 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.99 | $0.99 | +0.00 (+0.3%) |
| 2026-03-31 | $0.78 | $0.87 | +0.09 (+11.6%) |
| 2025-12-31 | $0.94 | $0.97 | +0.03 (+3.1%) |
| 2025-09-30 | $0.83 | $1.15 | +0.32 (+37.8%) |
227 ratings from 28 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| BMO Capital | Maintained | Outperform | $75 $65 | Sep 4, 2026 |
| Barclays | Maintained | Overweight | $78 $75 | Sep 4, 2026 |
| JP Morgan | Maintained | Neutral | $71 $65 | Jul 14, 2026 |
| B of A Securities | Maintained | Neutral | $70 $68 | Jul 2, 2026 |
| Bernstein | Maintained | Market Perform | $72 $63 | Jul 2, 2026 |
| Piper Sandler | Reiterated | Overweight | $80 $78 | Jun 18, 2026 |
| Stephens & Co. | Maintained | Equal-Weight | $65 $70 | May 5, 2026 |
| Piper Sandler | Upgraded from Neutral | Overweight | $61 $75 | Apr 6, 2026 |
| Mizuho | Initiated from Buy | Outperform | $72 | Mar 26, 2026 |
| JP Morgan | Maintained | Neutral | $67 $65 | Mar 24, 2026 |
| JP Morgan | Maintained | Neutral | $63 $67 | Feb 3, 2026 |
| BMO Capital | Maintained | Outperform | $67 $73 | Feb 3, 2026 |
| Barclays | Maintained | Overweight | $75 $78 | Feb 3, 2026 |
| BMO Capital | Upgraded from Market Perform | Outperform | $60 $67 | Jan 8, 2026 |
| Piper Sandler | Maintained | Neutral | $58 $61 | Dec 12, 2025 |
| BMO Capital | Maintained | Market Perform | $53 $56 | Nov 11, 2025 |
| B of A Securities | Maintained | Neutral | $59 $58 | Oct 8, 2025 |
| Bernstein | Downgraded from Outperform | Market Perform | $74 $59 | Jul 23, 2025 |
| Goldman Sachs | Initiated | Buy | $67 | Jun 23, 2025 |
| Stephens & Co. | Maintained | Equal-Weight | $63 $61 | May 6, 2025 |
| JP Morgan | Maintained | Neutral | $63 $61 | May 6, 2025 |
| Citigroup | Maintained | Neutral | $59 $60 | Apr 15, 2025 |
| Stephens & Co. | Maintained | Equal-Weight | $60 $63 | Feb 4, 2025 |
| Piper Sandler | Upgraded from Underweight | Neutral | $58 | Feb 4, 2025 |
| Barclays | Maintained | Overweight | $76 $75 | Jan 21, 2025 |
78 filings from 26 insiders · 0 buy / 0 sell over 6m
Officers and directors of TSN, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Schomburger Jeffrey KDirector; Officer, President & CEO Elect | Buy | 19.4k | $51.50 | $1.00M | Sep 4, 2026 |
| MORRIS WESChief Operating Officer | Grant | 25.9k | — | — | Jul 10, 2026 |
| SCHOMBURGER JEFFREY KChief Executive Officer | Grant | 48.4k | — | — | Jul 10, 2026 |
| BRONCZEK DAVID JDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| TYSON BARBARA ADirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| TYSON OLIVIADirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| BOND SARAH R.Director | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| SCHOMBURGER JEFFREY KDirector | Grant | 3.8k | $65.26 | $245k | Feb 6, 2026 |
| QUINN KATHERINE BDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| BEEBE MIKE DDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| BALEDGE LES RDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| WHITE NOEL WDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| MARTINEZ MARIA N.Director | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| BORRAS MARIA CLAUDIADirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| MILLER CHERYL SDirector | Grant | 2.9k | $65.26 | $190k | Feb 6, 2026 |
| TYSON JOHN HChairman of the Board | Exercise | 109.2k | $50.00 | $5.46M | Nov 28, 2025 |
| TYSON JOHN HChairman of the Board | Sell | 100.3k | $58.05 | $5.82M | Nov 28, 2025 |
| CALAWAY CURTChief Financial Officer | Exercise | 6.5k | $50.00 | $327k | Nov 25, 2025 |
| CALAWAY CURTChief Financial Officer | Sell | 6.5k | $57.19 | $374k | Nov 25, 2025 |
| COLE DEVINChief Operating Officer | Grant | 54.6k | — | — | Nov 25, 2025 |
No analyst notes on TSN yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 2 | 2 | 8 | 0 | 1 | Hold2.69 |
| 1 mo ago | 2 | 2 | 8 | 0 | 1 | Hold2.69 |
| 2 mo ago | 2 | 2 | 8 | 0 | 1 | Hold2.69 |